Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
These are averages, and individual results depend on starting weight, adherence to lifestyle changes, and metabolic factors
It is taken as a weekly injection and has shown remarkable results in clinical trials, such as the SURMOUNT-1 trial, where participants lost significant body weight over 72 weeks
With FDA-approval of the Wegovy pill by Novo Nordisk in December 2025, the first oral versions ofGLP-1 weight loss medications are scheduled to reach the market in January 2026
Whilst routine pancreatic enzyme testing is not indicated in asymptomatic patients, clinicians should maintain a low threshold for investigation if symptoms develop
Plaintiffs will present qualified experts who can explain the growing epidemiological evidence, the biological mechanism connecting GLP-1 drugs to impaired optic nerve blood flow, and why the existing labels failed to give doctors a meaningful warning
